[1] Karbowski M, Neutzner A. Neurodegeneration as a consequence of failed mitochondrial maintenance [J]. Acta Neuropathol, 2012, 123(2): 157-171
[2] Clay Montier LL, Deng JJ, Bai Y. Number matters: control of mammalian mitochondrial DNA copy number [J]. J Genet Genomics, 2009, 36(3): 125-131
[3] Sadakierska-Chudy A, Frankowska M, Filip M. Mitoepigenetics and drug addiction [J]. Pharmacol Ther, 2014, 144(2): 226-233
[4] Ignatenko O, Chilov D, Paetau I, et al. Loss of mtDNA activates astrocytes and leads to spongiotic encephalopathy [J]. Nat Commun, 2018, 9(1): 70
[5] Fjell AM, McEvoy L, Holland D, et al. What is normal in normal aging? Effects of aging, amyloid and Alzheimer's disease on the cerebral cortex and the hippocampus [J]. Prog Neurobiol, 2014, 117: 20-40
[6] O'Day DH. Alzheimer's disease: a short introduction to the calmodulin hypothesis [J]. AIMS Neurosci, 2019, 6(4): 231-239
[7] Rice AC, Keeney PM, Algarzae NK, et al. Mitochondrial DNA copy numbers in pyramidal neurons are decreased and mitochondrial biogenesis transcriptome signaling is disrupted in Alzheimer's disease hippocampi [J]. J Alzheimers Dis, 2014, 40(2): 319-330
[8] Xu Y, Xu L, Han M, et al. Altered mitochondrial DNA methylation and mitochondrial DNA copy number in an APP/PS1 transgenic mouse model of Alzheimer disease [J]. Biochem Biophys Res Commun, 2019, 520(1): 41-46
[9] Coskun PE, Beal MF, Wallace DC. Alzheimer's brains harbor somatic mtDNA control-region mutations that suppress mitochondrial transcription and replication [J]. Proc Natl Acad Sci U S A, 2004, 101(29): 10726-10731
[10] Podlesniy P, Figueiro-Silva J, Llado A, et al. Low CSF concentration of mitochondrial DNA in preclinical Alzheimer disease [J]. Ann Neurol, 2013, 74(5): 655-668
[11] Delbarba A, Abate G, Prandelli C, et al. Mitochondrial alterations in peripheral mononuclear blood cells from Alzheimer's disease and mild cognitive impairment patients [J]. Oxid Med Cell Longev, 2016, 2016: 5923938
[12] Gambardella S, Limanaqi F, Ferese R, et al. ccf-mtDNA as a potential link between the brain and immune system in neuro-immunological disorders [J]. Front Immunol, 2019, 10: 1064
[13] Tysnes OB, Storstein A. Epidemiology of Parkinson's disease [J]. J Neural Transm(Vienna), 2017, 124(8): 901-905
[14] Pyle A, Anugrha H, Kurzawa-Akanbi M, et al. Reduced mitochondrial DNA copy number is a biomarker of Parkinson's disease [J]. Neurobiol Aging, 2016, 38: 216.e7-216.e10
[15] Pyle A, Brennan R, Kurzawa-Akanbi M, et al. Reduced CSF mitochondrial DNA is a biomarker for early-stage Parkinson's disease [J]. Ann Neurol, 2015, 78(6): 1000-1004
[16] Essawy SS, Tawfik MK, Korayem HE. Effects of adenosine receptor antagonists in MPTP mouse model of Parkinson's disease: mitochondrial DNA integrity [J]. Arch Med Sci, 2017, 13(3): 659-669
[17] Lowes H, Pyle A, Santibanez-Koref M, et al. Circulating cell-free mitochondrial DNA levels in Parkinson's disease are influenced by treatment [J]. Mol Neurodegener, 2020, 15(1): 10
[18] McColgan P, Tabrizi SJ. Huntington's disease: a clinical review [J]. Eur J Neurol, 2018, 25(1): 24-34
[19] Siddiqui A, Rivera-Sánchez S, Castro Mdel R, et al. Mitochondrial DNA damage is associated with reduced mitochondrial bioenergetics in Huntington's disease [J]. Free Radic Biol Med, 2012, 53(7): 1478-1488
[20] Petersen MH, Budtz-Jørgensen E, Sørensen SA, et al. Reduction in mitochondrial DNA copy number in peripheral leukocytes after onset of Huntington's disease [J]. Mitochondrion, 2014, 17: 14-21
[21] Christoforidou E, Joilin G, Hafezparast M. Potential of activated microglia as a source of dysregulated extracellular microRNAs contributing to neurodegeneration in amyotrophic lateral sclerosis [J]. J Neuroinflammation, 2020, 17(1): 135
[22] Wiedemann FR, Manfredi G, Mawrin C, et al. Mitochondrial DNA and respiratory chain function in spinal cords of ALS patients [J]. J Neurochem, 2002, 80(4): 616-625
[23] Gautam M, Xie EF, Kocak N, et al. Mitoautophagy: A unique self-destructive path mitochondria of upper motor neurons with TDP-43 pathology take, very early in ALS [J]. Front Cell Neurosci, 2019, 13: 489
[24] Stoccoro A, Mosca L, Carnicelli V, et al. Mitochondrial DNA copy number and D-loop region methylation in carriers of amyotrophic lateral sclerosis gene mutations [J]. Epigenomics, 2018, 10(11): 1431-1443
[25] Oh J, Vidal-Jordana A, Montalban X. Multiple sclerosis: clinical aspects [J]. Curr Opin Neurol, 2018, 31(6): 752-759
[26] Blokhin A, Vyshkina T, Komoly S, et al. Variations in mitochondrial DNA copy numbers in MS brains [J]. J Mol Neurosci, 2008, 35(3): 283-287
[27] Varhaug KN, Vedeler CA, Myhr KM, et al. Increased levels of cell-free mitochondrial DNA in the cerebrospinal fluid of patients with multiple sclerosis [J]. Mitochondrion, 2017, 34: 32-35
[28] Al-Kafaji G, Bakheit HF, Alharbi MA, et al. Mitochondrial DNA copy number in peripheral blood as a potential non-invasive biomarker for multiple sclerosis [J]. Neuromolecular Med, 2020, 22(2): 304-313
[29] Mousavizadeh K, Rajabi P, Alaee M, et al. Usage of mitochondrial D-loop variation to predict risk for Huntington disease [J]. Mitochondrial DNA, 2015, 26(4): 579-582
[30] Lin MT, Cantuti-Castelvetri I, Zheng K, et al. Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease [J]. Ann Neurol, 2012, 71(6): 850-854
[31] Coppede F, Stoccoro A. Mitoepigenetics and neurodegenerative diseases [J]. Front Endocrinol(Lausanne), 2019, 10: 86
[32] Blanch M, Mosquera JL, Ansoleaga B, et al. Altered mitochondrial DNA methylation pattern in Alzheimer disease-related pathology and in Parkinson disease [J]. Am J Pathol, 2016, 186(2): 385-397
[33] Stoccoro A, Siciliano G, Migliore L, et al. Decreased methylation of the mitochondrial D-loop region in late-onset Alzheimer's disease [J]. J Alzheimers Dis, 2017, 59(2): 559-564
[34] Baloh RH, Salavaggione E, Milbrandt J, et al. Familial parkinsonism and ophthalmoplegia from a mutation in the mitochondrial DNA helicase twinkle [J]. Arch Neurol, 2007, 64(7): 998-1000
[35] Palin EJH, Paetau A, Suomalainen A. Mesencephalic complex I deficiency does not correlate with parkinsonism in mitochondrial DNA maintenance disorders [J]. Brain, 2013, 136(Pt 8): 2379-2392
[36] Sheng B, Wang X, Su B, et al. Impaired mitochondrial biogenesis contributes to mitochondrial dysfunction in Alzheimer's disease [J]. J Neurochem, 2012, 120(3): 419-429
[37] Kim J, Moody JP, Edgerly CK, et al. Mitochondrial loss, dysfunction and altered dynamics in Huntington's disease [J]. Hum Mol Genet, 2010, 19(20): 3919-3935
[38] Thomas RR, Khan SM, Portell FR, et al. Recombinant human mitochondrial transcription factor A stimulates mitochondrial biogenesis and ATP synthesis, improves motor function after MPTP, reduces oxidative stress and increases survival after endotoxin [J]. Mitochondrion, 2011, 11(1): 108-118
[39] Ladd AC, Brohawn DG, Thomas RR, et al. RNA-seq analyses reveal that cervical spinal cords and anterior motor neurons from amyotrophic lateral sclerosis subjects show reduced expression of mitochondrial DNA-encoded respiratory genes, and rhTFAM may correct this respiratory deficiency [J]. Brain Res, 2017, 1667: 74-83
[40] Rodolfo C, Campello S, Cecconi F. Mitophagy in neurodegenerative diseases [J]. Neurochem Int, 2018, 117: 156-166
[41] Reddy PH, Oliver DM. Amyloid beta and phosphorylated Tau-induced defective autophagy and mitophagy in Alzheimer's disease [J]. Cells, 2019, 8(5):488
[42] Franco-Iborra S, Plaza-Zabala A, Montpeyo M, et al. Mutant HTT (huntingtin) impairs mitophagy in a cellular model of Huntington disease [J]. Autophagy, 2020,1-18. doi: 10.1080/15548627.2020.1728096
[43] Ge P, Dawson VL, Dawson TM. PINK1 and Parkin mitochondrial quality control: a source of regional vulnerability in Parkinson's disease [J]. Mol Neurodegener, 2020, 15(1): 20
[44] Sasaki S. Autophagy in spinal cord motor neurons in sporadic amyotrophic lateral sclerosis [J]. J Neuropathol Exp Neurol, 2011, 70(5): 349-359
[45] Castellazzi M, Patergnani S, Donadio M, et al. Correlation between auto/mitophagic processes and magnetic resonance imaging activity in multiple sclerosis patients [J]. J Neuroinflammation, 2019, 16(1): 131
[46] Patergnani S, Castellazzi M, Bonora M, et al. Autophagy and mitophagy elements are increased in body fluids of multiple sclerosis-affected individuals [J]. J Neurol Neurosurg Psychiatry, 2018, 89(4): 439-441 |